| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.32 | 6e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.21 | 8e-09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.32 | 7e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.33 | 1e-07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.26 | 9e-07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |